The relationship between serum angiotensin-converting enzyme and different clinical sub-types in patients with hepatitis B
LI Jian-xin
LIU Ming-xia
ZHAN Yu-xi
ZHENG Nan
ZHAN Xiang-cai
ZHANG Qing-yun
Abstract：Objective To discuss the angiotensin-converting enzyme (ACE) changes in different clinical sub-types of hepatitis B. Methods The fully automatic biochemical analyzer was used to detect ACE activity and to measure acetylcholine esterase activity (CHE) in samples from the different groups. Results Serum ACE activity among the different clinical sub-types was as follows: control group(23.47±6.03 )μmob/L; chronic viral hepatitis B (51.79±8.58) μmol/L; liver cirrhosis Child-Pugh A (60.57±6.4)μmol/L; liver cirrhosis Child-Pugh B (68.22 ±6.62)μmol/L; liver cirrhosis Child-Pugh C (77.3±8.3 )μmol/L Serum ACE activity in patients with virus hepatitis B was significantly higher than that in the control greup(P <0.01). When CHE was >4000 IU/L, the activity of ACE was(34.71±9.43 )μg/L. The differences between each group were all significant (P<0.01).Conclusion Serum activity of ACE in clinical sub-types of hepatitis B had clinical significance for assessing the degree of liver cell injury.
Keywords：Hepatitis BAngiotensin-converting enzymeCholinesteraseClinical classification
Publication Date：2009-01-01
Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)
Pages：2( 448-449 )